International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Lett 12: [Related article:] 3679-3682, 2016; DOI: 10.3892/ol.2016.5200
Following the publication of this article, an interested reader drew to our attention that the flow of the text, and the wording of numerous passages of text within the article, bore striking and unexpected similarities to the wording employed in a PhD thesis by Salam Khan at the Karolinska Institutet in Stockholm in 2015 entitled “Targeting Chronic Lymphocytic Leukemia cells using Anti-ROR1 Monoclonal Antibodies and Small Molecule Inhibitors”.
After having conducted an internal investigation, the Editor of Oncology Letters has determined beyond all reasonable doubt that the review submitted to the Journal shared an unacceptable level of identity with the PhD thesis by Salam Khan. The authors were contacted about these apparent similarities between their review and the thesis, and they agree to this retraction. The Editor of Oncology Letters deeply regrets that this article was not intercepted by our own checks for plagiarism prior to the publication of the review, and sincerely apologizes to the author of the PhD thesis and the readership for the inconvenience caused. We also thank the reader for bringing this matter to our attention.